Microplastics and Misinformation: What Science Really Says
November 12, 2025
Brand Name :
N/A
Synonyms :
rimiterol
Class :
BronchodilatorÂ
Dosage Forms & StrengthsÂ
Dry powder (inhaler)Â
250 mcg/doseÂ
Chronic Obstructive Pulmonary Disease (COPD)Â
As metered-dose aerosol:
Inhaled dose of 250 to 500 mcg when required
Dose should not be more than 8 times in a day
Do not repeat dose in less than 1 hour
Not determined Â
Refer to adult dosingÂ
rimiterol: it may decrease activities of antihypertensive drugs
rimiterol: it may decrease activities of antihypertensive drugs
rimiterol: it may decrease activities of antihypertensive drugs
rimiterol: it may decrease activities of antihypertensive drugs
rimiterol: it may decrease activities of antihypertensive drugs
Actions and SpectrumÂ
rimiterol is a direct-acting sympathomimetic having selective action on 2-receptors and adrenergic activity. Â
Frequency not defined Â
PalpitationsÂ
Muscle cramps Â
TachycardiaÂ
Nervous tension Â
headacheÂ
Peripheral vasodilatation Â
Hypersensitivity reactionsÂ
Black Box WarningÂ
None
Contraindication/Caution:Â
None
Pregnancy consideration:Â
Pregnancy category: N/AÂ
Lactation: Excretion into human milk is unknown Â
Pregnancy Categories:        Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women. Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.Â
Category N: There is no data available for the drug under this category.Â
Pharmacology Â
rimiterol is a direct-acting sympathomimetic that primarily inhibits adrenergic activity while selectively acting on 2-receptors.Â
PharmacodynamicsÂ
None Â
PharmacokineticsÂ
Limited information available on ADME
AdministrationÂ
rimiterol is administered via inhalation using a metered-dose inhaler (MDI).Â
Patient information leafletÂ
Generic Name: rimiterolÂ
Why do we use rimiterol?Â
rimiterol is used for the treatment of respiratory conditions characterized by bronchodilation. Â
rimiterol is also used in the management of COPD, which includes conditions like asthma.Â